Print Page   |   Sign In   |   Join Now!
News & Press: Legislative & Regulatory

Notice of Rulemaking Activity

Monday, March 9, 2015   (0 Comments)
Posted by: Tijonne Edmond
Share |

The following information has been released by the Louisiana Board of Pharmacy.

 

Regulatory Project 2015-1 ~ Dispenser Reporting to Prescription Monitoring Program
Regulatory Project 2015-2 ~ Expiration Date of Schedule II Prescriptions

With respect to Regulatory Project 2015-1 ~ Dispenser Reporting to Prescription Monitoring Program, the Board initiated this project to comply with the provisions of Act 472 of the 2014 Regular Session of the Louisiana Legislature.  Effective on August 1, 2014, that law changed the deadline by which pharmacies dispensing prescriptions for controlled substances are required to report those prescription transactions to the PMP database, from seven days after the date of dispensing to the next business day after the date of dispensing.  With this regulatory project, the Board seeks to amend the rules for the Prescription Monitoring Program to place the same reporting deadline in the rules.  In addition, this regulatory project also seeks to amend the definition of "drug of concern" in the PMP rules, to remove the drug product tramadol.  This was made necessary when the federal DEA placed that drug into Schedule IV of the federal list of controlled substances.  The Board published its Notice of Intent in the December 2014 edition of the Louisiana Register, and then held a public hearing on January 28, 2015 to receive comments and testimony on the proposed rule.  During their subsequent meeting on February 25, 2015, the Board considered the absence of any comments or testimony at that public hearing, determined that no revisions were necessary, and directed the continuation of the promulgation process.  The Board has now filed its Second Report to the Joint Legislative Oversight Committee on Health and Welfare for its consideration.

With respect to Regulatory Project 2015-2 ~ Expiration Date of Schedule II Prescriptions, the Board initiated this project to comply with the provisions of Act 865 of the 2014 Regular Session of the Louisiana Legislature.  Effective on August 1, 2014, that law changed the expiration date of prescriptions for drugs listed in Schedule II, from six months to ninety days.  With this regulatory project, the Board seeks to amend its rules for controlled substances to place the same expiration date in the rules.  The Board published its Notice of Intent in the December 2014 edition of the Louisiana Register, and then held a public hearing on January 28, 2015 to receive comments and testimony on the proposed rule.  During their subsequent meeting on February 25, 2015, the Board considered the absence of any comments or testimony at that public hearing, determined that no revisions were necessary, and directed the continuation of the promulgation process.  The Board has now filed its Second Report to the Joint Legislative Oversight Committee on Health and Welfare for its consideration.


Copyright © 2010 Louisiana Pharmacists Association. All Rights Reserved.
620 Florida St., Suite 210 | Baton Rouge, LA 70801 | (225) 346-6883 | Fax (225) 344-1132

Association Management Software Powered by YourMembership  ::  Legal